The U.S. Food and Drug Administration approved Astellas' therapy to treat a type of gastric cancer, the health regulator's ...

Recent clinical research from BGI Genomics and Zhongshan Hospital, Fudan University, highlights the effectiveness of ...

FDA also approved the Ventana CLDN18 (43-14A) RxDx Assay, from Ventana Medical Systems, Inc. and Roche Diagnostics, to ...

A ChatGPT-like model can diagnose cancer, assist in selecting treatment options, and predict survival outcomes across various ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved VYLOY™ (zolbetuximab-clzb) in combination ...

VYLOY is the first and only CLDN18.2-targeted treatment approved in the U.S. for adults with advanced gastric and gastroesophageal junction cancer whose tumors are CLDN18.2 positive TOKYO, Oct. 18 ...

Graves disease and cancer were associated with each other, as Graves disease diagnosis was linked to increased risks for ovarian and prostate cancers.

A sweeping new report finds alcohol consumption may be increasing the risk of certain types of cancer. Other recent studies ...

Cancer rates have slightly decreased in Delaware over the past 15 years, but the First State is still ahead of the national ...

Gastric cancer, or stomach cancer ... plus anlotinib hydrochloride in patients with advanced gastric adenocarcinoma and esophageal squamous cell carcinoma.

Eating papaya on an empty stomach can help with weight loss, improve heart health, enhance skin glow, ease constipation, and ...